» Articles » PMID: 26175930

Polycomb Protein Family Member CBX7 Plays a Critical Role in Cancer Progression

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2015 Jul 16
PMID 26175930
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

CBX7 is a polycomb protein that participates in the formation of polycomb repressive complex 1. Apart from few exceptions, CBX7 expression is lost in human malignant neoplasias and a clear correlation between its downregulated expression and a cancer aggressiveness and poor prognosis has been observed. These findings indicate a critical role of CBX7 in cancer progression. Consistently, CBX7 is able to differentially regulate crucial genes involved in cancer progression and in epithelial-mesenchymal transition, as osteopontin and E-cadherin. Recent evidences indicate a role of CBX7 also in the modulation of response to therapy. In conclusion, CBX7 represents an important prognostic factor, whose loss of expression in general indicates a bad prognosis and a progression towards a fully malignant phenotype.

Citing Articles

RNF2 promotes chondrosarcoma progression by regulating ubiquitination and degradation of CBX7.

Wu Y, Huang Z, Luo P, Xiang Z, Zhang M, Chen Z Cancer Metab. 2024; 12(1):30.

PMID: 39456039 PMC: 11520121. DOI: 10.1186/s40170-024-00359-x.


Targeting the Ferroptosis and Endoplasmic Reticulum Stress Signaling Pathways by CBX7 in Myocardial Ischemia/reperfusion Injury.

Jiang W, Yan Z, Zheng X, Huang S, Hu Y, Xiong F Cell Biochem Biophys. 2024; 82(3):2171-2181.

PMID: 38809351 DOI: 10.1007/s12013-024-01324-7.


Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells.

Zhang Y, Tedja R, Millman M, Wong T, Fox A, Chehade H J Ovarian Res. 2023; 16(1):233.

PMID: 38037081 PMC: 10688490. DOI: 10.1186/s13048-023-01312-0.


CBX7 is involved in the progression of cervical cancer through the ITGβ3/TGFβ1/AKT pathway.

Tian P, Deng J, Ma C, Miershali A, Maimaitirexiati G, Yan Q Oncol Lett. 2023; 27(1):14.

PMID: 38028179 PMC: 10664064. DOI: 10.3892/ol.2023.14147.


Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells.

Zhang Y, Tedja R, Millman M, Wong T, Fox A, Chehade H bioRxiv. 2023; .

PMID: 37986971 PMC: 10659572. DOI: 10.1101/2023.11.07.566022.


References
1.
Berge G, Pettersen S, Grotterod I, Bettum I, Boye K, Maelandsmo G . Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis. Int J Cancer. 2010; 129(4):780-90. DOI: 10.1002/ijc.25735. View

2.
Gil J, Bernard D, Martinez D, Beach D . Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol. 2003; 6(1):67-72. DOI: 10.1038/ncb1077. View

3.
Matusan K, dordevic G, Stipic D, Mozetic V, Lucin K . Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma. J Surg Oncol. 2006; 94(4):325-31. DOI: 10.1002/jso.20447. View

4.
Mansueto G, Forzati F, Ferraro A, Pallante P, Bianco M, Esposito F . Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein. Genes Cancer. 2011; 1(3):210-24. PMC: 3092193. DOI: 10.1177/1947601910366860. View

5.
Sepe R, Formisano U, Federico A, Forzati F, Bastos A, DAngelo D . CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression. Oncotarget. 2015; 6(5):2680-92. PMC: 4413610. DOI: 10.18632/oncotarget.2777. View